CI_Business_Wire

Data Presented at UEG Week 2023 Further Support the Potential of Celltrion’s Investigational Subcutaneous Infliximab CT-P13 SC in the Treatment of Inflammatory Bowel Disease

The latest clinical trial data for subcutaneous (SC) infliximab (CT-P13 SC), presented at the United European Gastroenterology (UEG) Week 2023...

EFQM-Image

Winners of the EFQM business transformation awards announced at the 2nd Edition Of The EFQM The Middle East Summit “Shaping the Future Through Excellence, Agility and Sustainable Transformation”